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Abstract: 
Distinct effect of ent-Kaurene Diterpenoids from Isodon serra on abnormal proliferation of 
murine lymphocytes was examined with MTT assay and Flow Cytometry Analyses (FCAS). 
After choosing the most appropriate monomer from these Diterpenoids, we introduced mouse 
tumescence model to investigate whether it could impact cytokine production in vivo with 
ELISA assay. 
 
The result of MTT assay showed that four ent-Kaurene Diterpenoids could effectively suppress 
the murine splenic T lymphocytes overproduction stimulated by Concanavalin A, while 
inhibitive effect was softer on normal sleep lymphocytes than the stimulated ones. Among four 
ent-Kaurene Diterpenoids, Enmein was the most sensitive one with IC50/EC50 equaling to 1.55. 
This inhibitive activity was due to interfering DNA replication in G1-S stage and to regulating 
cell cycle according to flow cytometry analyses (FCAS) result. Xylene-induced mouse 
tumescence model result further suggested that Enmein depressed the murine ear swelling extent 
and the level of Interleukin-2 in blood serum in a dose-dependent manner. 
 
In conclusion, it demonstrated that four ent-Kaurene Diterpenoids from I. serra had distinct 
immunosuppressive effect in vitro and in vivo systems, which primarily differentiated Enmein 
from the others. The experimental results provided insight into a potential immunosuppressive 
action of Enmein as a promising drug, though profound mechanism remained to be further 
studied. 
 
Article: 
INTRODUCTION 
For over hundreds of years, traditional Chinese doctors have accumulated and developed 
considerable pharmacopoeias that are largely used in modern China and many other parts of the 
world [1]. Isodon serra (MAXIM.) HARA, named Xi Huangcao in Chinese, is distributed in 
Southeast area of P.R. China. As a perennial herb, it has been popularly used for treatment of 
arthritis, enteritis, jaundice, hepatitis, lepromatous leprosy, ascariasis and acute cholecystitis [2]. 
It is known that cyclophosphamide is an antitumor medicine which also has immunosuppressive 
activity. Correspondingly, I. serra monomers were reported to vary in efficacy especially for 
anti-tumor biological activity [3] and [4]. In our study, we aimed to explore other functions like 
immunosuppressive activity of these I. serra extracts besides their antitumor activity [5]. 
 
Recently, our studies [6] on I. serra extracts have led to the isolation of some novel ent-Kaurene 
Diterpenoids, which showed molecular components and potential inhibitive activities in T 
lymphocytes proliferation. However, detailed comparison of inhibitive activities among these 
extracts has not been reported before. So major objective of our study is to differentiate the most 
immunosuppressive compound from these ent-Kaurene Diterpenoids both in vitro and in vivo 
experimental models. 
 
MATERIALS AND METHODS 
Reagents 
Four ent-Kaurene Diterpenoids of I. serra were extracted and purified by school of Pharmacy, 
Shanghai Jiao Tong University, P.R. China [6]. Chemical structures of these ent-Kaurene 
Diterpenoids were shown in Fig. 1. Purity of these ent-Kaurene Diterpenoids was over 98%. 
These extracted monomers were respectively observed for their pharmaceutical efficiency in the 
following experimental models. 
 
 
Figure 1: Chemical structures of ent-Kaurene Diterpenoids from Isodon serra. 
 
 
It was reported that multi-glycoside from Tripterygium wilfordii Hook f. (GTW) was used for 
various immune and inflammatory diseases in China [7] and [8]. GTW had suppressive effects on 
acute inflammatory changes most likely by reducing expression of injurious cytokines [9]. Here 
GTW (obtained from Fujian-Huitian Biological Pharmacy Co.) was used as the positive reference 
substance in vitro models. Since tacrolimus (FK506) was a clinical drug with great 
immunosuppressive activity [10], FK506 (obtained from Fujisawa Ireland Ltd.) was designed as 
positive group in mouse tumescence model. 
 
Animals 
Pathogen-free female/male BALB/c mice weighing 20 ± 2 g, 8–10 weeks of age, were purchased 
from ShangHai Center of Experimental Animals, Chinese Academy of Sciences. License 
number: SCXK (Shanghai) 2003–0003.The animals were fed in our SPF standards animal 
laboratory with 24 ± 2 °C and 50% humidity, and with a 12-h light/dark cycle. They were 
provided with sterilized food and water. They would not be applied to our experiment until they 
were fed for 1 week obtained from ShangHai Center of Experimental Animals. 
 
Splenocyte isolation 
Fresh lymphocyte suspensions were prepared before each experiment from male BALB/c mice. 
They were exsanguinated, and then spleens were immediately excised. Cells derived from 
spleens sequentially passed through a 100-mesh screen to harvest for mononuclear lymphocytes 
suspension. Erythrocytes were lysed with Gey's reagent for 5 min [11]. Cells were then washed 
with sterile phosphate buffered saline (PBS). Mononuclear lymphocytes were isolated by 
buoyant density centrifugation (5 min at 1000 rpm). After that, the isolated splenic lymphocytes 
were resuspended at 1 × 106 cells/ml in RPMI-1640 medium (Sigma Co.) supplemented with 
10% (v/v) heat-inactivated bovine serum (GIBCO Co.). Cells were cultured in 96 well tissue 
culture plates with 2 × 105 lymphocytes per well [12]. They were incubated at 37 °C in a 
humidified atmosphere of 5% carbon dioxide (CO2) for the indicated period. The recovered cells 
were typically > 98% viable as assessed by Trypan blue exclusion, and the heterogeneous 
mononuclear cell suspension mainly consisted of 40% B cells and 60% T cells. 
 
Cell viability 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) (Gibico) was diluted to 5 
mg/ml in PBS and filtered once through a 0.22-μm filter. The diluted MTT was under protected 
from light at 4 °C and used within a month. MTT colorimetric assay was applied to study 
cytotoxicity of ent-Kaurene Diterpenoids from I. serra. 
 
Briefly, isolated splenocytes (100 μl/well) were cultured in 96 well tissue culture plates in the 
presence of these compounds separately. MTT was added after 48 h at a final concentration of 
500 μg/ml and incubated for 4 h. After removal of MTT, the formazan precipitate was 
solubilized in DMSO (100 μl/well) and measured on a microplate reader model 550(Bio-rad, 
California, USA) at the absorbance wavelength of 570 nm and reference wavelength of 655 nm. 
The experiment was repeated three times. Viability rate of cells = average OD of test 
team / average OD of control team × 100%. Half inhibitive concentration (IC50) here meant the 
drug concentration when viability rate of cells reached 50%. 
 
Excessive multiplication response 
Murine splenic lymphocytes were aliquotted in 96-well plates (100 μl/well) and stimulated by 
Concanavalin A (ConA) (Sigma). Meanwhile ent-Kaurene Diterpenoids were added. GTW took 
the positive groups. The lymphocytes survival was measured with MTT assay. The experiment 
was repeated three times. Viability rate of T-lymphocytes = average OD of test team / average 
OD of control team × 100%. Half effective concentration (EC50), which was employed as the 
activity evaluating parameter, here meant the drug concentration when the viability rate of T-
lymphocytes equaled 50%. 
 
Flow cytometry analysis 
Flow cytometry analysis was applied to investigate whether these monomers had DNA synthesis 
interdiction of activated T-lymphocytes [13]. Briefly, ConA-induced cells were cultured with 
Enmein or GTW. After 48 h, cells were trypsinized to form single-cell suspension, and were 
diluted to 1 × 106 cells/ml. After rinsed twice with cold PBS, cells were fixation with PBS 
containing 70% of methanol for 1 h at 4 °C. Subsequently they were treated with Rnase A for 30 
min and then with Trypsin (0.5%w/v) and EDTA (0.2% w/v) for 5 min. Finally, cells were 
stained with propidium iodide (PI) and analysed in a FACScan flow cytometer. We analyzed 
10,000 events for each sample. 
 
Mouse tumescence model 
Ear-swelling response in murine was an experimental animal model, which was concerned with 
the recruitment and the activation of immune and inflammatory cells [14] and [15]. This 
tumescence model had advantages of little difference, high sensitivity and repeatability, etc. 
BALB/c mice, 8–10 weeks of age, were used for this experimental animal model. Briefly, 
male/female BALB/c mice were separately divided into several groups. Enmein was separately 
injected into mice at the dose of 6.52 mg/kg (LOW), 9.78 mg/kg (MID) or 13.04 mg/kg (HIGH) 
for 5 days; in parallel, mice treated with tacrolimus (FK506) (1 mg/kg) were divided as positive 
group. These doses were all conversion quantities of clinical dosages. On the 5th day, 1 h after 
administering, we injected xylene into the left ear of each mouse. Forty minutes later, mice blood 
specimens of Enmein-treated groups were collected and stored at − 20 °C. After the mice were 
executed, murine ear weight was then quantified. 
 
To evaluate pharmaceutical efficacy, ear tumescence extent was calculated as follows: Degree of 
ear swelling = (Mleft ear − Mright ear) / Mmouse. Mleft ear indicated net weight of each left murine ear; 
Mright ear indicated net weight of each right murine ear; Mmouse indicated weight of each mouse. 
 
Enzyme-linked immunosorbent assay (ELISA) 
The production of cytokine (Interleukin-2) in blood serum (collected before) was measured by a 
standard sandwich cytokine ELISA procedure to assess the pharmaceutical effect on cytokine 
quantity in vivo model. Standards (recombinant cytokine at 0, 15.63, 31.25, 62.5, 125, 250, 500, 
1000 pg/ml concentrations) and samples were added in 100 μl/well. Cytokine quantities in the 
samples were calculated from standard curves of recombinant cytokines using a regression linear 
method. The assay was performed with manufacturer's instructions of mouse Interleukin-2 kits 
from R&D systems (Minneapolis, MN). Absorbance results were assessed using an ELISA 
microplate reader set (Multiskan Ex, Lab systems, Finland). 
 
Statistical analysis 
Statistical analysis was performed using the Origin 7.0 software to evaluate the significance of 
differences between groups. In all these graphs, * indicated significantly different than untreated 
groups, p < 0.05; ** indicated significantly different than untreated groups, p < 0.01; *** 
indicated significantly different than untreated groups, p < 0.001. All data points represented the 
mean of triplicates. 
 
RESULTS 
Cytotoxicity evaluation of I. serra extracts in vitro 
Splenic lymphocytes (1 × 106 cells/ml) were treated with I. serra extracts at different 
concentrations (3.13, 6.25, 12.5, 25 μg/ml) in 48 h. These extracts were measured by MTT 
method that exhibited different cytotoxicity. In Fig. 2a, drug concentration was taken for 
horizontal coordinates, and cells viability rate for vertical coordinates. The result showed that the 
inhibitive activity of Enmein on lymphocytes with highest viability rate was much lower than of 
Lasiodonin, Nodosin and Epinodosin. Within concentration from 6.25 μg/ml to 25 μg/ml, the 
inhibitive activity of Enmein on lymphocytes appeared statistical significant difference 
(p < 0.001). Moreover, GTW (positive reference substance) showed slight inhibitive effect on 
lymphocytes. Most data here showed statistical differences (p < 0.01). 
 
 
Figure 2: Cytotoxicity evaluation of Isodon serra extracts in vitro. (a) Cells were cultured with various 
concentrations of GTW (■), Enmein (●), Nodosin (▲), Lasiodonin (□) and Epinodosin (○) separately. Drug 
concentration was taken for horizontal coordinates, and cells viability rate for vertical coordinates. The inhibition of 
Enmein with highest viability rate was much lower than that of Lasiodonin, Nodosin and Epinodosin. From 6.25 
μg/ml to 25 μg/ml, the activity of Enmein on lymphocytes showed statistical significant difference (p < 0.001). (b) 
Each column represented Half-inhibiting concentration (IC50) of corresponding drug on normal lymphocytes. IC50 
of Enmein was the highest among four extracts, reaching 17 μg/ml. And IC50 of Lasiodonin came to 10 μg/ml. IC50 
for each I. serra extract showed the following order: Enmein > Lasiodonin > Nodosin > Epinodosin. *Indicated 
significant difference between control group and experimental group, p < 0.05; **indicated significant difference 
between control-induced group and experimental group, p < 0.01; ***indicated significantly difference control-
induced group and experimental group, p < 0.001. 
 
 
Half inhibitive activity (IC50) for each I. serra extract was estimated based on results in Fig. 2a. 
In Fig. 2b, each column represented IC50 of corresponding compound. The IC50 of Enmein was 
highest among four extracts, reaching 17 μg/ml. Meanwhile, the IC50 of Lasiodonin came to 10 
μg/ml. The IC50 of these extracts showed the following order: 
Enmein > Lasiodonin > Nodosin > Epinodosin (Fig. 2b). 
 
Inhibitive activity evaluation to over-activated T lymphocytes 
ConA-induced lymphocytes (1 × 106 cells/ml) were treated with various concentrations of I. 
serra extracts in the range of 3.13–25 μg/ml in 48 h. The concentration of ConA was held 
constant at 3 μg/ml. Then they were measured by MTT method. In Fig. 3a, from 3.13 to 25 
μg/ml, the viability rate of Nodosin-treated lymphocytes went down 75% and to 5% at 48 h, 
while the viability rate of Enmein-treated cells went to 20%. Moreover, GTW (positive reference 
substance) also showed significant inhibitive activity on lymphocytes. Most data here appeared 
statistical significant difference (p < 0.001). 
 
Half effective concentration (EC50) of I. serra extracts was estimated based on results in Fig. 3a. 
In Fig. 3b, each column represented EC50 of corresponding compound to ConA-induced murine 
splenic T lymphocytes. The EC50 of Nodosin was the lowest in four extracts, reaching 5.5 μg/ml. 
Meanwhile, the EC50 of Enmein reached 11 μg/ml. The EC50 of these extracts showed the 
following order: Nodosin < Epinodosin < Enmein < Lasiodonin. 
 
Designated as a therapeutic index, the ratio of IC50 versus EC50 was estimated for each target 
compound based on results in Fig. 2 and Fig. 3. When counting up above-mentioned results, the 
ratio of these extracts showed the following order: 
Enmein > Nodosin > Epinodosin > Lasiodonin successively (Fig. 3c). Among four ent-Kaurene 
Diterpenoids, Enmein was the most sensitive one with IC50/EC50 equaling to 1.55. 
 
In conclusion, according to ConA-induced T lymphocytes proliferation model (Fig. 3c), Enmein 
was the most excellent ent-Kaurene Diterpenoids from I. serra. They had all shown inhibitive 
activity to cells over-proliferation and primarily immunosuppressive activity. Consequently, we 
carried out further research around Enmein by flow cytometry analysis. 
 
 
Figure 3: Inhibitive activity evaluation of Isodon serra extracts on over-activated T lymphocytes. (a) Splenic 
lymphocytes were cultured with ConA in the presence of various concentrations of GTW (■), Enmein (●), Nodosin 
(▲), Lasiodonin (□) and Epinodosin (○) for 48 h and quantitated by MTT assay. Drug concentration was taken for 
horizontal coordinates, and cells viability rate for vertical coordinates. The concentration of each compound was 
varied as indicated (units: μg/ml). Between 3.13 μg/ml and 25 μg/ml, the result indicated that the viability rate of 
Nodosin-treated lymphocytes was down from 75% and to 5% at 48 h, when the viability rate of Enmein-treated cells 
remained 20%. Most data here appeared statistical significant difference (p < 0.001). (b) Each column represented 
half effected concentration (EC50) from different I. serra extract by ConA-induced lymphocytes. The EC50 of 
Nodosin was the lowest in four extracts, reaching 5.5 μg/ml. Meanwhile, the EC50 of Enmein reached 11 μg/ml. The 
EC50 for I. serra extracts showed the following order: Nodosin < Epinodosin < Enmein < Lasiodonin. (c) The ratio 
of IC50 versus EC50 designated as a therapeutic index was estimated for each target compound based on results in 
Figs. 2b and part (b) of this figure. Counting up above-mentioned results, the ratio of IC50 versus EC50 for I. serra 
extracts showed the following order: Enmein > Nodosin > Epinodosin > Lasiodonin successively. Among four ent-
Kaurene Diterpenoids, Enmein was the most sensitive one with IC50/EC50 equaling to 1.55. *Indicated significant 
difference between ConA-induced group and experimental group, p < 0.05; **indicated significant difference 
between ConA-induced group and experimental group, p < 0.01; ***indicated significantly difference ConA-
induced group and experimental group, p < 0.001. 
 
 
Interference effect on cell cycle by flow cytometry analysis 
Results above indicated that the optimal concentration of Enmein was higher than EC50 and 
lower than IC50 (11–17 μg/ml). According to this, we affirmed the middle dose at 11 μg/ml 
(MID), the low dose at 5.5 μg/ml (LOW), and the high dose at 22 μg/ml (HIGH). We performed 
activity of Enmein on cell cycle by Flow cytometry analysis (Fig. 4). ConA-induced T 
lymphocytes were treated with Enmein at 5.5 μg/ml (LOW), 11 μg/ml (MID) or 22 μg/ml 
(HIGH) or with GTW at 11 μg/ml (MID) or 22 μg/ml (HIGH) in 48 h, making normal 
lymphocytes as a control. 
 
The results of FCAS assay (Fig. 4a) indicated that after lymphocytes were exposed to Enmein for 
48 h, percentage of G1 stage cells increased from 78% to 93% that was equal to normal control 
group (93%). Results in Fig. 4b showed that Enmein could mainly cause the percentage of S 
stage cells decreased from 19% to 6% that was equal to normal control group (6%). The data in 
Fig. 4c obviously indicated that Enmein could mainly cause the percentage of G2/M stage cells 
to decrease from 2% to 0.4% which was equal to normal control group (0.58%). 
 
Effect on mouse xylene-induced ear tumefaction 
The degree of tumefaction was a useful marker for autoimmune activation and also played a 
crucial role in triggering activation of inflammatory [14] and [15]. Here we adopted xylene-
induced murine ear tumefaction model to investigate the immunosuppressive effect of Enmein in 
vivo. The result (Fig. 5a and b) indicated that the xylene-induced ear swelling was evidently 
inhibited both in female and male mice treated with FK506 (1 mg/kg) or Enmein at the dose of 
6.52 mg/kg (LOW), 9.78 mg/kg (MID) or 13.04 mg/kg (HIGH) for 5 days. Compared with the 
control group, significantly inhibitive activity was noticed in Enmein groups, in a dose-
dependant manner especially for male mice. 
 
Figure 4: Interdiction effect of Enmein on cell cycle by flow cytometry analysis. ConA-induced lymphocytes were 
treated with Enmein at 5.5 μg/ml (LOW), 11 μg/ml (MID) or 22 μg/ml (HIGH) or GTW at 11 μg/ml (MID) or 22 
μg/ml (HIGH) in 48 h, making normal lymphocytes as a control. (a) The results of FCAS assay indicated that after 
lymphocytes were exposed to Enmein for 48 h, the percentage of G1 stage cells increased from 78% to 93% that was 
equal to normal control group (93%). (b) The chart obviously showed that Enmein could mainly cause the 
percentage of S stage cells decreased from 19% to 6% that was equal to normal control group (6%). (c) The data 
indicated that Enmein could mainly cause the percentage of G2/M stage cells decreased from 2% to 0.4% that was 
equal to normal control group (0.58%). 
 
 
 
Figure 5: Effect of Enmein on mouse xylene-induced ear tumefaction. (a) It was observed that the xylene-induced 
ear swelling was significantly inhibited in female mice treated with FK506 (1 mg/kg) or Enmein separately at the 
dose of 6.52 mg/kg (LOW), 9.78 mg/kg (MID) and 13.04 mg/kg (HIGH) for 5 days. Inhibitive activity on ear 
swelling was noticed in Enmein groups that were more significant than FK506 group, compared with the control 
group. (b) It was observed that the xylene-induced ear swelling was significantly inhibited in male mice treated with 
FK506 or Enmein for 5 days. Compared with the control group, significantly inhibition on ear swelling was noticed 
in Enmein groups, in a dose-dependant manner. *Indicated significant difference between control and experimental, 
p < 0.05; **indicated significant difference between control and experimental, p < 0.01. 
 
 
Effect on cytokine production in vivo 
We directly tested Interleukin-2 levels in blood serum specimens from experimental animal 
model above through an ELISA procedure. In Fig. 6, the IL-2 concentration in high-dose-treated 
group (13.04 mg/kg) was lower than that in low-dose-treated group (6.52 mg/kg). Compared 
with control group, inhibition of enmein was significantly noticed in a dose-dependant manner. 
In a word, the increased level of inflammatory cytokine (Interleukin-2) was attenuated by the 
treatment of Enmein in vivo model. 
 
 
Figure 6: Effect of Enmein on cytokine production in vivo. We directly tested Interleukin-2 levels by an ELISA 
procedure. The concentration of IL-2 in low-dose-treated group (6.52 mg/kg) was higher than that in control group, 
while the concentration of IL-2 in high-dose-treated group (13.04 mg/kg) was much lower. Compared with control 
group, inhibition to Interleukin-2 was significantly noticed in a dose-dependant manner. *Indicated significant 
difference between control and experimental, p < 0.05. 
 
 
DISCUSSION 
Cell proliferation was clearly accommodated within a chronic disease state such as rheumatoid 
arthritis (RA), where there was T cell infiltration of synovium and marked cytokine production 
[16], because stimulated T cells were able to support osteoclast formation [17]. According to the 
analysis of cell viability in vitro, I. serra extracts could significantly inhibit abnormally high 
splenic T lymphocyte (ConA-induced), while they had softer inhibitive activity on resting 
lymphocytes. We found that the efficiency of cellular immunosuppression was in the following 
order: Enmein > Nodosin > Epinodosin > Lasiodonin. Considering that the other extracts had 
lower therapeutic index (IC50/EC50) than Enmein, we anticipated that the most appropriate drugs 
(Enmein), whose optimal concentration was higher than EC50 and lower than IC50 (11–17 
μg/ml), would be beneficial. Some studies on Isodon genus extracts had discovered Enmein[5]. 
There was no information available for its immune activity, even though Enmein was the 
primary agent of I. serra. Among our extracts, it contained 3 mg Enmein/100 g raw material but 
only 0.2 mg Epinodosin/100 g raw material. In this paper, we discovered the immunosuppressive 
activity of Enmein as follows. Just as expected, an inhibitive activity was observed through the 
flow cytometry analysis assay. It showed that percentage of Enmein-treated cells (in 5.5–22 
μg/ml ranges) in the S and G2/M stage obviously decreased to the normal levels, while number 
of cells in the G1 stage increased to the normal levels in a dose-dependant manner. This 
phenomenon implied that Enmein influenced cell cycle through inhibiting DNA replication. So it 
suggested that inhibitive activity of Enmein on T lymphocytes multiplication maybe related to 
interdiction of DNA replication in the G1-S stage and to regulation of cell mitosis cycle. Herein, 
we had primarily made the choice of the most appropriate compound (Enmein) from these ent-
Kaurene Diterpenoids. 
 
It was well known that rheumatoid arthritis was characterized by synoviocytes proliferation and 
articular cartilage tissue tumefaction. These pathological changes resulted from a profile of 
increased plasma levels of the proinflammatory cytokines Interleukin-2, which was thought to 
play an important role in the pathogenesis of RA [18]. Besides, T cells initiated the inflammatory 
cascade through secretion of IL-2 that was higher in the long-lasting RA [19]. Preliminary 
studies in our laboratory showed that I. serra extracts inhibited the proliferation of mitogen-
stimulated cultures of murine splenic T lymphocytes in vitro. Therefore, we tested production of 
IL-2 for the hypothesis that I. serra extracts altered T lymphocyte activation by modulating 
cytokines IL-2. In xylene-induced mouse ear swelling experiment, as we expected, Enmein (from 
6.52 mg/kg to 13.04 mg/kg) inhibited not only the mouse ear swelling extent, but also the 
production of IL-2 in murine blood serum dose-dependently. We supposed that it might be the 
important mechanism of immunosuppressive activity of Enmein. Such a unique modulation from 
Enmein might point to distinct signaling mechanisms for induction of IL-2. 
 
In conclusion, from all the results we attained, it demonstrated that four ent-Kaurene 
Diterpenoids from I. serra had distinct immunosuppressive effect in vitro and in vivo. Enmein, 
which we selected for the most appropriate compound, was expected to be a promising drug for 
autoimmune disease such as rheumatoid arthritis. In order to promote research and development 
of I. serra extracts, more methods in pharmacological studies would be employed. For example, 
collagen-induced arthritis (CIA) and adjuvant induced Arthritis (AA) experimental animal 
models will be taken in our future investigation. As a promising immunosuppressive compound, 
more pharmacological activity and detailed mechanism of Enmein would be illuminated in 
future. 
 
ABBREVIATIONS 
ConA   Concanavalin A  
IL-2   Interleukin-2  
RA   rheumatoid arthritis  
PBS   phosphate buffered saline 
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